• Open Hours: Mon - Sat 9.00 - 18.00
  • Mon - Sat : 9.00 - 18.00

Best Dry Eyes Treatment in Chandigarh

Complete Dry Eyes Suite

30+

Years in Eye Care

10,000+

Surgeries Per Year

16

Eye Specialists

70,000+

Patients Per Year

30+

Years in Eye Care

10, 000+

Surgeries Per Year

16

Eye Specialists

70,000+

Patients Per Year

About Grewal Eye Institute

Dry eye doesn’t mean that people can’t weep. Dry eye is a disorder related with quality of tears and not the quantity of tears. The two predominant types of dry eye are the aqueous deficient (which is relatively rare) and more common the lipid deficient, accounting for vast majority of dry eye. 

Aqueous deficient dry eye occurs when the tear glands do not secrete enough tears to keep the eyes sufficiently moist. Lipid deficient dry eye, also known as evaporative dry eye, occurs when the tears evaporates at a faster rate than normal due to an inadequate protective lipid (oil) layer on the surface of the tear film.

Oils are produced by Meibomian Glands in the lids. Missing of these oily layers is the reason behind MGD. LipiFlow has major role in treatment of MGD. Evaporative dry eye is the most prevalent type affecting up to 86% of dry eye sufferers.

Dry Eye Symptoms and Identifying MGD

If you are experiencing burning and redness, ocular fatigue, foreign body sensation, sensitivity to light, excessive tearing, symptoms worsen later in the day, transient blurring and contact lens intolerance, you may be suffering from Meibomian Gland Dysfunction (MGD) or Dry Eyes. In all cases of dry eyes, it is important to test for MGD to direct treatment appropriately. These tests help us to better understand the meibomian function and structure. Dry eye workup is needed to identify the cause and direct the treatment for aqueous deficient dry eye, MGD and ocular allergy. Dry eye sufferers experience great discomfort and are desperately seeking new approach as in addition to traditional therapies, which only provide limited symptomatic relief.
Dry Eye
Normal Eye

About LipiFlow Activator

LipiFlow Activator, a single-use sterile device, safely and comfortably delivers automated therapeutic energies to each meibomian gland while protecting the delicate structures of the patient’s eye. This treatment provides a level of accuracy and quality that allows eye care professionals to treat their MGD patients with confidence and ease.

Its contoured design vaults the cornea and protects the eye allowing a maximum therapeutic temperature of 43 degrees Celsius to reach glands from the inner eyelid, without damaging the eyelid or delicate structures of the globe. Space-age insulation protects the cornea from exceeding a safe 39.5 degrees Celsius, while an intelligent pressure feedback loop sends pulsed sequences to expel blockages. Force equalization protects the globe from pressure transmission by focussing energy only on the eyelid.

Cause of Dry Eyes

Dry eye is a condition in which a person doesn’t have enough quality tears to lubricate and nourish the eye. About one and half litre tears are made in each eye every day. With every blink, tears are pushed into nose and a fresh lot of tears comes to eye. It is a highly complex functional eco system. Dry eye is a common and often chronic problem, particularly in older adults.

Major factors:

Age: Dry eyes are a part of the natural aging process. The majority of people over age 65 experience some symptoms of dry eyes.

Gender: Women are more likely to develop dry eyes due to hormonal changes caused by pregnancy, the use of oral contraceptives and menopause.

Medications: Certain medicines, including antihistamines, decongestants, blood pressure medications and antidepressants, can reduce tear production.

Ready to see the difference? Book your eye appointment today!
Book an Appointment

LipiFlow: Clinical Efficiency

LipiFlow is FDA-cleared and validated by large multi-center, randomized, controlled clinical studies.

Randomized, controlled clinical trials of LipiFlow have shown statistically significant improvements in meibomian gland function. The same studies have also shown significant improvement in patient self-reported dry eye symptoms. LipiFlow has successfully treated tens of thousands of patients globally.

Clinical trials have shown significant improvement, on average, in the clinical sign of number of meibomian glands yielding clear liquid. The study showed significant improvement, on average, in patient self-reported dry eye symptoms.